{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:54:44Z","timestamp":1792461284819,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejpn.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T02:11:22Z","timestamp":1687140682000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Metachromatic leukodystrophy: To screen or not to screen?"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-4409","authenticated-orcid":false,"given":"An I.","family":"Jonckheere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-2257","authenticated-orcid":false,"given":"Sandra D.K.","family":"Kingma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Eyskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Bordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2023.06.005_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.576221","article-title":"Metachromatic leukodystrophy: diagnosis, modeling, and treatment approaches","volume":"7","author":"Shaimardanova","year":"2020","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40348-020-00103-7","article-title":"Early clinical course after hematopoietic stem cell transplantation in children with juvenile metachromatic leukodystrophy","volume":"7","author":"Beschle","year":"2020","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.ejpn.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report","volume":"10","author":"Boucher","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib4","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1212\/WNL.0000000000011047","article-title":"Association of age at onset and first symptoms with disease progression in patients with metachromatic leukodystrophy","volume":"96","author":"Kehrer","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejpn.2023.06.005_bib5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jimd.12388","article-title":"Metachromatic leukodystrophy: a single-center longitudinal study of 45 patients","volume":"44","author":"Fumagalli","year":"2021","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ejpn.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1469-8749.2011.04028.x","article-title":"The natural course of gross motor deterioration in metachromatic leukodystrophy","volume":"53","author":"Kehrer","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib7","first-page":"96","article-title":"Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review","volume":"60","author":"Videbaek","year":"2021","journal-title":"JIMD Rep"},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13023-019-1060-2","article-title":"Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers","volume":"14","author":"Harrington","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"National marrow donor P, international bone marrow transplant R, working party on inborn errors EBMTG. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"10322","key":"10.1016\/j.ejpn.2023.06.005_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejpn.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0036-1584602","article-title":"Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"47","author":"Boelens","year":"2016","journal-title":"Neuropediatrics"},{"issue":"8249","key":"10.1016\/j.ejpn.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/bloodadvances.2017010645","article-title":"Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies","volume":"2","author":"van den Broek","year":"2018","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.ejpn.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13023-019-1220-4","article-title":"Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective","volume":"14","author":"Beerepoot","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ejpn.2023.06.005_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/0883073815595078","article-title":"Outcome of early juvenile onset metachromatic leukodystrophy after unrelated cord blood transplantation: a case series and review of the literature","volume":"31","author":"Chen","year":"2016","journal-title":"J.\u00a0Child Neurol."},{"issue":"5","key":"10.1016\/j.ejpn.2023.06.005_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1705581","article-title":"Early marrow transplantation in a pre-symptomatic neonate with late infantile metachromatic leukodystrophy does not halt disease progression","volume":"39","author":"Bredius","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbmt.2013.01.010","article-title":"Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy","volume":"19","author":"Martin","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"24","key":"10.1016\/j.ejpn.2023.06.005_bib19","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood-2016-03-708479","article-title":"Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience","volume":"127","author":"van Rappard","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejpn.2023.06.005_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.ejpn.2023.06.005_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bmt.2012.155","article-title":"Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort","volume":"48","author":"Krageloh-Mann","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.ejpn.2023.06.005_bib22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ana.21522","article-title":"Umbilical cord blood transplantation for juvenile metachromatic leukodystrophy","volume":"64","author":"Pierson","year":"2008","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2023.06.005_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3174\/ajnr.A1739","article-title":"Metachromatic leukodystrophy: a scoring system for brain MR imaging observations","volume":"30","author":"Eichler","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/088307389901400402","article-title":"Slow progression of juvenile metachromatic leukodystrophy 6 years after bone marrow transplantation","volume":"14","author":"Kapaun","year":"1999","journal-title":"J.\u00a0Child Neurol."},{"issue":"8","key":"10.1016\/j.ejpn.2023.06.005_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/bmt.2014.93","article-title":"Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy","volume":"49","author":"Solders","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.ejpn.2023.06.005_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bmt.2010.252","article-title":"Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature","volume":"46","author":"de Hosson","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3727\/096368912X656117","article-title":"Advances and pitfalls of cell therapy in metabolic leukodystrophies","volume":"22","author":"Miranda","year":"2013","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2009.10.006","article-title":"Transplant outcomes in leukodystrophies","volume":"47","author":"Orchard","year":"2010","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/acn3.50975","article-title":"Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction","volume":"7","author":"Wolf","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"10043","key":"10.1016\/j.ejpn.2023.06.005_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(16)30450-0","article-title":"Therapies of lysosomal storage disorders targeting the brain","volume":"388","author":"Krageloh-Mann","year":"2016","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.ejpn.2023.06.005_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1042\/bj20020249","article-title":"Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages","volume":"368","author":"Muschol","year":"2002","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.gt.3301593","article-title":"Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations","volume":"9","author":"Matzner","year":"2002","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.ejpn.2023.06.005_bib33","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI200419205","article-title":"Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells","volume":"113","author":"Biffi","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"issue":"11","key":"10.1016\/j.ejpn.2023.06.005_bib34","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1172\/JCI28873","article-title":"Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice","volume":"116","author":"Biffi","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"issue":"10043","key":"10.1016\/j.ejpn.2023.06.005_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejpn.2023.06.005_bib36","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jnr.23792","article-title":"Gene therapy for metachromatic leukodystrophy","volume":"94","author":"Rosenberg","year":"2016","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-017-0052-4","article-title":"Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I","volume":"40","author":"Penati","year":"2017","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddi425","article-title":"Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy","volume":"15","author":"Sevin","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.ejpn.2023.06.005_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2012.015","article-title":"Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice","volume":"23","author":"Piguet","year":"2012","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.ejpn.2023.06.005_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","article-title":"Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain","volume":"13","author":"Cearley","year":"2006","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/humc.2014.139","article-title":"Intracerebral gene therapy using AAVrh.10-hARSA recombinant vector to treat patients with early-onset forms of metachromatic leukodystrophy: preclinical feasibility and safety assessments in nonhuman primates","volume":"26","author":"Zerah","year":"2015","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib42","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.ymgme.2017.12.352","article-title":"Intracerebral gene therapy in children with metachromatic leukodystrophy: results of a phase I\/II trial","volume":"123","author":"Sevin","year":"2018","journal-title":"Mol. Genet. Metabol."},{"issue":"23","key":"10.1016\/j.ejpn.2023.06.005_bib43","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/hmg\/ddaa277","article-title":"Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy","volume":"29","author":"Kaminski","year":"2021","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.ejpn.2023.06.005_bib44","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/hmg\/ddr175","article-title":"Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy","volume":"20","author":"Stroobants","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.ejpn.2023.06.005_bib46","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"Matthes","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/acn3.51254","article-title":"Intravenous arylsulfatase A in metachromatic leukodystrophy: a phase 1\/2 study","volume":"8","author":"Id","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ejpn.2023.06.005_bib48","first-page":"235","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: results from a phase 1\/2 clinical trial","volume":"131","author":"Id","year":"2020","journal-title":"Mol. Genet. Metabol."},{"issue":"12","key":"10.1016\/j.ejpn.2023.06.005_bib49","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1515\/hsz-2013-0219","article-title":"Molecular triggers of neuroinflammation in mouse models of demyelinating diseases","volume":"394","author":"Barrette","year":"2013","journal-title":"Biol. Chem."},{"issue":"11","key":"10.1016\/j.ejpn.2023.06.005_bib50","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","article-title":"Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells","volume":"181","author":"Jeon","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejpn.2023.06.005_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep24579","article-title":"Cerebral spinal fluid levels of cytokines are elevated in patients with metachromatic leukodystrophy","volume":"6","author":"Thibert","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejpn.2023.06.005_bib52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/mt.2015.69","article-title":"Anti-inflammatory therapy with simvastatin improves neuroinflammation and CNS function in a mouse model of metachromatic leukodystrophy","volume":"23","author":"Stein","year":"2015","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.ejpn.2023.06.005_bib53","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejpn.2023.06.005_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainres.2009.09.017","article-title":"Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy","volume":"1300","author":"Luzi","year":"2009","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2009.07.010","article-title":"Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1","volume":"36","author":"Smith","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.ejpn.2023.06.005_bib56","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ejpn.2023.06.005_bib57","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1021\/acsmedchemlett.0c00120","article-title":"Brain penetrable inhibitors of ceramide galactosyltransferase for the treatment of lysosomal storage disorders","volume":"11","author":"Thurairatnam","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93601-1","article-title":"Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor","volume":"11","author":"Babcock","year":"2021","journal-title":"Sci. Rep."},{"issue":"7\u20138","key":"10.1016\/j.ejpn.2023.06.005_bib59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/scd.2021.0352","article-title":"Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy","volume":"31","author":"Cabanillas Stanchi","year":"2022","journal-title":"Stem Cell. Dev."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/crispr.2021.0075","article-title":"A\u00a0mutation-agnostic hematopoietic stem cell gene therapy for metachromatic leukodystrophy","volume":"5","author":"Antony","year":"2022","journal-title":"CRISPR J"},{"issue":"10","key":"10.1016\/j.ejpn.2023.06.005_bib61","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"van der Knaap","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2023.06.005_bib62","first-page":"281","article-title":"[Principles and practice of mass screening for disease]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol. Oficina Sanit. Panam."},{"issue":"3","key":"10.1016\/j.ejpn.2023.06.005_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41436-020-01017-5","article-title":"Toward newborn screening of metachromatic leukodystrophy: results from analysis of over 27,000 newborn dried blood spots","volume":"23","author":"Hong","year":"2021","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1373\/clinchem.2015.245159","article-title":"Sulfatide analysis by mass spectrometry for screening of metachromatic leukodystrophy in dried blood and urine samples","volume":"62","author":"Spacil","year":"2016","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ejpn.2023.06.005_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ymgme.2022.09.009","article-title":"Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - chances and challenges","volume":"137","author":"Santhanakumaran","year":"2022","journal-title":"Mol. Genet. Metabol."},{"issue":"2","key":"10.1016\/j.ejpn.2023.06.005_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijns8020025","article-title":"A\u00a0new approach to objectively evaluate inherited metabolic diseases for inclusion on newborn screening programmes","volume":"8","author":"Burlina","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.ejpn.2023.06.005_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijns8010020","article-title":"Application of a novel algorithm for expanding newborn screening for inherited metabolic disorders across europe","volume":"8","author":"Jones","year":"2022","journal-title":"Int J Neonatal Screen"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823000958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379823000958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:40:47Z","timestamp":1761072047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379823000958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":67,"alternative-id":["S1090379823000958"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.06.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metachromatic leukodystrophy: To screen or not to screen?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}